Q2 2020 Kindred Biosciences Inc Earnings Call

5/8/2020 16:30

Conference Call Kindred Biosciences Inc

Kindred Biosciences Inc Conference call will be held on Aug 5, 2020. During the earnings conference call's session Kindred Biosciences Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Kindred Biosciences Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
We are a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Our mission is to bring to our pets the same kinds of safe and effective medicines that our human family members enjoy. Our core strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for pets, primarily dogs, cats and horses. We believe this approach will lead to shorter development times and higher approval rates than pursuing new, non-validated compounds and targets. We completed a pivotal field efficacy trial, or pivotal trial, of ZimetaTM (dipyrone injection) with positive topline results and have submitted to the U.S. Food and Drug Administration, or FDA, the Chemistry, Manufacturing and Controls, or CMC, and the Effectiveness technical sections of the New Animal Drug Application, or NADA.    
Read more Conference Call

Kindred Biosciences Inc (KIN)

1555 Bayshore Highway, Burlingame California 94010, United States